| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:2000 |
| IHC | 1:50-1:200 |
| IF | 1:50-1:200 |
| FC | 1:50-1:200 |
Citrate synthase serves as the gateway enzyme of the tricarboxylic acid cycle, catalyzing the condensation of acetyl-CoA and oxaloacetate to form citrate in the mitochondrial matrix. As a key regulator of cellular energy metabolism, CS expression and activity are frequently examined in studies of mitochondrial function, metabolic disorders, oxidative capacity, and exercise physiology. Its consistent expression across tissues also makes it a widely used marker for mitochondrial content and integrity.
This recombinant rabbit monoclonal antibody against human citrate synthase offers the reproducibility that metabolic research demands. Generated from a defined sequence and produced through recombinant technology, it eliminates the lot-to-lot variability inherent to traditional hybridoma-derived antibodies, ensuring your quantitative comparisons remain valid across extended studies.
Validation data demonstrates robust performance across multiple experimental platforms. In western blot applications, the antibody detects a clean band at the predicted 52 kDa molecular weight across diverse human cell lines including SH-SY5Y, HEK293, HeLa, MCF-7, K562, and Jurkat cells, as well as mouse NIH/3T3 cells and rat brain tissue, confirming reliable cross-species reactivity. Immunohistochemistry staining has been validated in human glioma and kidney tissue sections, while immunofluorescence studies in HeLa cells reveal the expected mitochondrial localization pattern. Flow cytometry validation in PC-3 cells demonstrates clear positive population shifts suitable for single-cell metabolic profiling.
This antibody supports researchers investigating mitochondrial biogenesis, cellular respiration, cancer metabolism, neurodegeneration, and exercise-induced adaptations where accurate CS quantification is essential for meaningful biological conclusions.
Email: support@cusabio.com
Distributors Worldwide